
Company Info
Phone(305) 600-1048
Year Established
2007
Contacts
Anthony J. Capobianco, Ph.D.Founder & CEO
Company Description
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on the discovery and development of novel therapeutics that target mechanisms fundamental to cancer, such as Wnt, Notch, and Myc signaling.